UNAUDITED INTERIM RESULTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
| % change |
Unaudited six months ended 31 December 2023 R'000 |
Unaudited six months ended 31 December 2022 R'000 |
Audited year ended 30 June 2023 R'000 |
|
| Healthcare services revenue | 6.0 | 2 296 423 | 2 167 451 | 4 403 691 |
|---|---|---|---|---|
| Healthcare services operating costs | (7.0) | (1 991 248) | (1 861 590) | (3 801 696) |
| IFRS 16: Lease reversals | (8.6) | 38 242 | 41 842 | 75 241 |
| Healthcare services operating profit | (1.2) | 343 417 | 347 703 | 677 236 |
| Healthcare retail revenue | (3.1) | 2 087 963 | 2 154 694 | 4 464 341 |
| Healthcare retail cost of sales | 5.0 | (1 644 944) | (1 731 137) | (3 590 850) |
| Healthcare retail operating costs | (12.0) | (321 770) | (287 270) | (677 168) |
| Healthcare retail operating profit | (11.0) | 121 249 | 136 287 | 196 323 |
| Total healthcare operating profit | (4.0) | 464 666 | 483 990 | 873 559 |
| Fair value gains | 3 437 | 4 462 | 16 245 | |
| Other income | 5 559 | — | 2 570 | |
| Impairment of assets and loans | (892) | — | (27 115) | |
| Scrapping of intangible assets | — | — | (5 415) | |
| Net finance and investment costs | (34 055) | (34 826) | (72 343) | |
| — Finance and dividend income | 14 043 | 9 085 | 21 850 | |
| — Finance costs: Lease liabilities | (8 241) | (7 749) | (16 964) | |
| — Finance costs | (39 857) | (36 162) | (77 229) | |
| Share-based payment expense | (7 339) | (5 970) | (17 837) | |
| Share of profits from associates and joint ventures | 2 505 | 5 325 | 14 051 | |
| Profit before depreciation and amortisation | (4.2) | 433 881 | 452 981 | 783 715 |
| Depreciation | (2.9) | (44 947) | (43 666) | (82 976) |
| Right of use assets depreciation | (2.0) | (31 949) | (31 320) | (65 380) |
| Amortisation of intangible assets | 11.4 | (94 805) | (107 047) | (208 823) |
| Profit before taxation | (3.2) | 262 180 | 270 948 | 426 536 |
| Taxation expense | (0.9) | (77 204) | (76 504) | (131 654) |
| Profit for the period from continuing operations | (4.9) | 184 976 | 194 444 | 294 882 |
| Loss on disposal of subsidiary | — | (198) | (198) | |
| Profit for the period | (4.8) | 184 976 | 194 246 | 294 684 |
| Other comprehensive (loss)/income | (1 001) | 2 853 | 8 684 | |
| Comprehensive net income for the period | (6.7) | 183 975 | 197 099 | 303 368 |
| Attributable to: | ||||
| Equity holders of the Parent | 172 760 | 127 827 | 191 357 | |
| Non-controlling interest | 11 215 | 69 272 | 112 011 | |
| 183 975 | 197 099 | 303 368 |